Pulmonology & Critical Care
- Acute Respiratory Failure
- ARDS
- Asthma
- COPD
- Treatment
- Antibiotics
- AECOPD
- Pharmacotherapy
- Treatment
- ICU
- EMCRIT: Fluids/Electrolytes
- 3SITES: Subclavian less CLABSIs and DVTs than jugular/femoral, more PTX
- 65: MAP target 60-65 in pts ≥65 did not have mortality difference in vasodilatory shock
- Routine vs. On-Demand CXR in MV pts in the ICU increases use 34%, no benefit
- LACTATE: Decreased in-hospital mortality and shorter ICU stay with aim of 20% reduction q2hrs for the first 8 hours in ICU; guided group received more fluids and started vasopressors earlier but did not have faster rate of reduction in lactate
- PRORATA: <10% increase in mortality at 30-60 days with procalcitonin-guided ABX
- SPICE-III: Precedex had more ADE w/o improving mortality as primary sedative in MV
- SOAP-II: Dopamine = NE for 1st line; Dopamine has increased risk of arrhythmias
- Septic Shock
- Interstitial Lung Disease (ILD)
- Lung Cancer
- Pleural Effusion
- Sleep Apnea